A detailed history of Handelsbanken Fonder Ab transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 17,823 shares of AGIO stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,823
Previous 16,123 10.54%
Holding current value
$1.05 Million
Previous $695,000 13.96%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$41.19 - $49.72 $70,023 - $84,524
1,700 Added 10.54%
17,823 $792,000
Q2 2024

Aug 05, 2024

BUY
$27.55 - $48.83 $112,955 - $200,203
4,100 Added 34.1%
16,123 $695,000
Q4 2023

Feb 01, 2024

BUY
$19.97 - $24.53 $57,913 - $71,137
2,900 Added 31.79%
12,023 $268,000
Q4 2022

Feb 07, 2023

BUY
$24.81 - $31.52 $39,696 - $50,432
1,600 Added 21.27%
9,123 $256,000
Q3 2022

Oct 27, 2022

BUY
$19.51 - $34.14 $146,773 - $256,835
7,523 New
7,523 $213,000
Q2 2022

Aug 03, 2022

SELL
$17.06 - $31.42 $199,994 - $368,336
-11,723 Closed
0 $0
Q2 2021

Aug 03, 2021

SELL
$52.06 - $61.27 $140,562 - $165,429
-2,700 Reduced 18.72%
11,723 $646,000
Q1 2021

Apr 29, 2021

BUY
$44.23 - $57.5 $225,572 - $293,250
5,100 Added 54.7%
14,423 $745,000
Q4 2020

Feb 11, 2021

SELL
$33.21 - $46.54 $3.4 Million - $4.77 Million
-102,400 Reduced 91.66%
9,323 $404,000
Q3 2020

Nov 13, 2020

SELL
$33.87 - $55.93 $467,405 - $771,834
-13,800 Reduced 10.99%
111,723 $3.91 Million
Q2 2020

Aug 13, 2020

BUY
$34.45 - $53.48 $1.53 Million - $2.38 Million
44,523 Added 54.97%
125,523 $6.71 Million
Q1 2020

May 14, 2020

BUY
$31.52 - $53.81 $788,000 - $1.35 Million
25,000 Added 44.64%
81,000 $2.87 Million
Q4 2019

Feb 14, 2020

SELL
$30.08 - $50.59 $3.01 Million - $5.06 Million
-100,000 Reduced 64.1%
56,000 $2.67 Million
Q3 2019

Oct 31, 2019

SELL
$32.4 - $49.58 $972,000 - $1.49 Million
-30,000 Reduced 16.13%
156,000 $5.05 Million
Q1 2019

May 10, 2019

SELL
$45.92 - $67.67 $413,280 - $609,030
-9,000 Reduced 4.62%
186,000 $12.5 Million
Q4 2018

Jan 31, 2019

BUY
$42.73 - $76.53 $918,694 - $1.65 Million
21,500 Added 12.39%
195,000 $8.99 Million
Q3 2018

Oct 19, 2018

BUY
$71.67 - $91.95 $788,370 - $1.01 Million
11,000 Added 6.77%
173,500 $13.4 Million
Q2 2018

Jul 11, 2018

BUY
$73.22 - $99.55 $4.03 Million - $5.48 Million
55,000 Added 51.16%
162,500 $13.7 Million
Q1 2018

May 18, 2018

BUY
$59.83 - $86.53 $598,300 - $865,300
10,000 Added 10.26%
107,500 $8.79 Million
Q4 2017

Feb 21, 2018

BUY
$52.12 - $72.33 $5.08 Million - $7.05 Million
97,500 New
97,500 $5.57 Million
Q4 2017

Feb 08, 2018

SELL
$52.12 - $72.33 $5.08 Million - $7.05 Million
-97,500 Closed
0 $0
Q3 2017

Nov 01, 2017

BUY
$54.89 - $67.12 $5.35 Million - $6.54 Million
97,500
97,500 $6.51 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.24B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.